Introduction: plantar fasciitis is most common cause of chronic heel pain. Platelet rich plasma is a new treatment modality that can be beneficial in refractory cases. The purpose of this study is to determine the effectiveness and safety of local PRP injection in plantar fasciitis. Materials and Methods: Thirty-two cases (23 females and 9 males) were treated by local injection of PRP at heel in Arihant Hospital and Research Centre, Indore between October 2016 to September 2017 and followed-up in this prospective study. AOFAS hind foot score and Roles-Maudsley score were used to determine improvement in pain. Results:The mean age of the patients was 45.71±12.1 years (range 23-67 years) and female dominant. Mean duration of symptoms was 11.7±6.7 months (range 6 months to 24 months). Only patients having symptoms for more than 3 months with no relief from conservative treatment were involved in study. The initial mean AOFAS hind foot score, 44.41 ± 3.25 improved to 91.31 ± 7.37 at 9 month follow up, which was statistically significant (p<0.05). The Roles-Maudsley score improved from poor in all the patients to 90.6% patients having good to excellent roles-maudsley score at 9 month follow up. Four patients required a repeat injection at 3 months, from which one patient showed no improvement while rest had significant improvement. Conclusion: local injection of Platelet rich plasma is an effective and safe method in refractory cases of plantar fasciitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.